Background illustration for clinical trials search

Paid Clinical Trials Annapolis

Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,396

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

for

Urothelial Cancer, Bladder Cancer, Genitourinary Cancer,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04923178

Recruiting

Buprenorphine for Individuals in Jail

for

Opioid Use Disorder

Location: Baltimore MD

Sponsor: Friends Research Institute, Inc.

Sex: All

Age: 18+

Code: NCT06306443

Phase3, Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for

Renal Cell Carcinoma (RCC),

Location: Baltimore MD, Hershey PA, Philadelphia PA,

Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase1, Recruiting

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

for

Diabetes Mellitus

Location: Baltimore MD

Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT06918977

Recruiting

PREVENT ALL ALS Study

for

Amyotrophic Lateral Sclerosis

Location: Baltimore MD, Washington D.C. DC, Bethesda MD,

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix

Sex: All

Age: 18+

Code: NCT06581861

Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

for

Acute Promyelocytic Leukemia (APL),

Location: Baltimore MD, Charlottesville VA, The Bronx NY,

Sponsor: Quetzal Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07504458

Phase3, Recruiting

Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant

for

Hairy Cell Leukemia

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04322383

Phase2, Recruiting

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

for

Idiopathic CD4 Lymphopenia

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70

Code: NCT04097561

Phase1, Recruiting

Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction

for

Breast Cancer, Mastectomy; Lymphedema, Same Day Surgery,

Location: Baltimore MD, Washington DC

Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT04596683

Recruiting

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

for

Advanced Clear Cell Renal Carcinoma (Ccrcc),

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05665361

Phase1, Phase2, Recruiting

Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4

for

Stargardt-Like Macular Dystrophy

Location: Bethesda MD

Sponsor: National Eye Institute (NEI)

Sex: All

Age: 10 - 70+

Code: NCT04591483

Recruiting

An Assessment of Cognitive Improvement Training Among Mid-life Individuals

for

Delay Discounting

Location: Baltimore MD

Sponsor: University of Kansas

Sex: All

Age: 40 - 60

Code: NCT03501706

Recruiting

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

for

Neurofibromatosis 1

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT04750928

Phase1, Phase2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for

Acute Coronary Syndrome

Location: Washington D.C. DC, Bethesda MD, Newark DE, Hershey PA,

Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

New

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight

for

Chronic Weight Management

Location: Baltimore MD

Sponsor: Ascletis Pharma (China) Co., Limited

Sex: All

Age: 18 - 65

Code: NCT07842640

Phase1, Recruiting

Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea

for

Obesity, Diabetes, Obstructive Sleep Apnea

Location: Bethesda MD

Sponsor: Mid-Atlantic Epilepsy and Sleep Center, LLC

Sex: All

Age: 18 - 70

Code: NCT02069197

Phase2, Recruiting

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

for

Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe,

Location: Washington DC, Rockville MD

Sponsor: Evon Medics LLC

Sex: All

Age: 18 - 70

Code: NCT04850664

Phase2, Recruiting

A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)

for

Pneumococcal Infection

Location: Columbia MD, Charlottesville VA, East Syracuse NY,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 1

Code: NCT07300267

Phase1, Recruiting

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

for

Shigella

Location: Baltimore MD

Sponsor: Eveliqure Biotechnologies GmbH

Sex: All

Age: 18 - 50

Code: NCT07049159

Phase2, Recruiting

Primary Tumor Research and Outcomes Network

for

Spinal Column Tumor

Location: Baltimore MD, New York NY, Providence RI, Boston MA,

Sponsor: AO Innovation Translation Center

Sex: All

Age: 0+

Code: NCT02790983

Recruiting

Paid Clinical Trials Annapolis

Filter results

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Buprenorphine for Individuals in Jail

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

PREVENT ALL ALS Study

Interested in new trials?

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4

An Assessment of Cognitive Improvement Training Among Mid-life Individuals

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight

Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

Primary Tumor Research and Outcomes Network